Archives

While CRISPR has grabbed the lion’s share of gene-editing headlines, Precision BioSciences has used its own gene-editing technology to quietly

Global Blood Therapeutics hasn’t finished testing its treatment for sickle cell disease, but the South San Francisco, CA-based company thinks

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: PADR-EF-2018Pillar: Preparatory Action on Defence Research (PADR)Opening Date: Deadline: Thu, 28 Jun 2018 17:00:00 (Brussels local time)Modification

This week, the Minority Staff of the U.S. Senate Committee on Finance released a report entitled, “A Tangled Web: An

Biotech crops in the last 22 years have brought enormous benefits to the environment, health of humans and animals, and

Helix, which runs an online outlet for products based on customer DNA, has bought HumanCode, one of the app makers

[Source: Research & Innovation] Abnormal heart rhythm is a major cause of cardiovascular disease and death in Europe. An EU-supported

Exosome Diagnostics, a company that has developed technology to test for disease by analyzing blood and other bodily fluids, has

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-SC1-BHC-2018-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Tue, 2 Oct 2018 17:00:00 (Brussels local time)Modification Date: Mon, 25

Jeffrey Lawson has been appointed CEO of regenerative medicine company Humacyte. Lawson had been chief medical officer of the Research